Clinical Trial Update: LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women [Phase 4]

View source ↗

Summary

Phase 4 trial from the University of Pennsylvania evaluated lisdexamfetamine dimesylate (LDX) with functional MRI in menopausal women, focusing on brain activit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• LDX (lisdexamfetamine dimesylate) (lisdexamfetamine dimesylate)

Snippet

Sponsor: University of Pennsylvania | Conditions: Menopause, Brain Activity | Phase 4 | Status: COMPLETED | Results posted: 2017-07-11